ID   XDCMHi001-A
AC   CVCL_WT97
DR   BioSamples; SAMEA5070575
DR   hPSCreg; XDCMHi001-A
DR   SKIP; SKIP005796
DR   Wikidata; Q98135136
RX   PubMed=32388440;
CC   From: Xiaoshan District Chinese Medicine Hospital; Hangzhou; China.
CC   Sequence variation: Mutation; HGNC; 6192; JAK2; Simple; p.Tyr570Cys (c.1709A>G); Zygosity=Heterozygous (PubMed=32388440).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
RX   PubMed=32388440; DOI=10.1016/j.scr.2020.101788;
RA   Hu J.-T., Ren W.-F., Qiu W.-G., Lv J.-L., Zhang C., Xu C., Du W.-B.,
RA   Wu M.-R., Wang J.-F., Quan R.-F.;
RT   "Generation of induced pluripotent stem cell line (XDCMHi001-A) from
RT   an ankylosing spondylitis patient with JAK2 mutation.";
RL   Stem Cell Res. 45:101788-101788(2020).
//